17.05.2015 Views

14-1190b-innovation-managing-risk-evidence

14-1190b-innovation-managing-risk-evidence

14-1190b-innovation-managing-risk-evidence

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

170<br />

Peacock, W. J. and Dennis, E. S. Inheritance of<br />

Trans Chromosomal Methylation patterns<br />

from Arabidopsis F1 hybrids. Proc. Natl Acad. Sci.<br />

USA. 111, 2017–2022 (20<strong>14</strong>).<br />

7. Jones, J. D. G. et al. Elevating crop disease<br />

resistance with cloned genes. Phil. Trans. R. Soc.<br />

Lond. B 369, 20130087 (20<strong>14</strong>).<br />

Chapter 11 Case Study: Standards:<br />

Supporting emerging technologies as an<br />

accelerator of <strong>innovation</strong><br />

1. Taylor, J. M. New Dimensions for Manufacturing:<br />

A UK Strategy for Nanotechnology (Department<br />

of Trade and Industry, London, 2002). Available<br />

at http://webarchive.nationalarchives.gov.<br />

uk/20130221185318/http://www.innovateuk.<br />

org/_assets/pdf/taylor%20report.pdf<br />

2. BSI is appointed by Her Majesty’s Government<br />

as the UK National Standards Body (NSB),<br />

and represents the United Kingdom on<br />

the international and European standards<br />

organizations ISO, IEC, CEN, CENELEC and<br />

ETSI. BSI’s scope covers all industry sectors,<br />

and its staff facilitates committees of experts<br />

that draft the standards they need on any<br />

business issue. BSI manages around 1,200<br />

standards committees in total, including<br />

around 200 international and European<br />

committees. See http://www.bsigroup.co.uk/<br />

Chapter 12: Ultimately a Decision Has To Be<br />

Made<br />

1. Watson, J. D. and Crick, F. H. C. A structure for<br />

Deoxyribose Nucleic Acid. Nature 171, 737-8<br />

(1953).<br />

2. I completed my two terms as Chair of the<br />

HFEA in January 20<strong>14</strong>. I write here in a<br />

personal capacity.<br />

3. A previous successful consultation exercise on<br />

human-admixed embryos provided us with a<br />

good starting point.<br />

4. Detailed information on these processes, plus<br />

all the material used in the consultation can be<br />

found at http://www.hfea.gov.uk/<br />

5. HFEA New techniques to prevent mitochondrial<br />

disease. See http://mitochondria.hfea.gov.uk/<br />

mitochondria/what-is-mitochondrial-disease/<br />

new-techniques-to-prevent-mitochondrialdisease/<br />

6. There were in fact 3 reports from the ‘panel<br />

of experts’ over the consultation period, in<br />

order to keep the scientific findings up to<br />

date. The first two were chaired by Prof. Neva<br />

Haites, the third by Dr. Andy Greenfield.<br />

7. Mongomery, J. et al. Novel techniques<br />

for the prevention of mitochondrial DNA<br />

disorders: an ethical view (Nuffield Council<br />

on Bioethics, London, 2012). Available at<br />

http://nuffieldbioethics.org/wp-content/<br />

uploads/20<strong>14</strong>/06/Novel_techniques_for_<br />

the_prevention_of_mitochondrial_DNA_<br />

disorders_compressed.pdf<br />

8. Mitochondria replacement consultation: Advice to<br />

Government (HFEA, London, 2013). Available<br />

at http://www.hfea.gov.uk/docs/Mitochondria_<br />

replacement_consultation_-_advice_for_<br />

Government.pdf<br />

9. Mitochondrial Donation: Government response to<br />

the consultation on draft regulations to permit the<br />

use of new treatment techniques to prevent the<br />

transmission of a serious mitochondrial disease<br />

from mother to child (Department of Health,<br />

London, 20<strong>14</strong>). Available at https://www.gov.<br />

uk/government/uploads/system/uploads/<br />

attachment_data/file/332881/Consultation_<br />

response.pdf<br />

10. House of Commons Debate 1 September<br />

20<strong>14</strong>, vol 585, cols 93-122 (Hansard). Available<br />

at http://www.publications.parliament.<br />

uk/pa/cm20<strong>14</strong>15/cmhansrd/cm<strong>14</strong>0901/<br />

debtext/<strong>14</strong>0901-0003.htm#<strong>14</strong>090125000001<br />

Annex: How to Build Regulatory<br />

Frameworks for New Technologies<br />

1. Dominique Auverlot, France Stratégie<br />

(dominique.auverlot@strategie.gouv.fr) ;<br />

Marie-Françoise Chevallier – Le Guyader,<br />

Institut des hautes études pour la science<br />

et la technologie ; Françoise Roure, CGE ;<br />

Jean-Luc Pujol, INRA; Aude Teillant, Research,<br />

Department of Ecology & Evolutionary<br />

Biology, Princeton University ; Clélia Godot,<br />

France Stratégie.<br />

2. Quelle France dans dix ans, rapport de France<br />

Stratégie au président de la République,<br />

Éditions Fayard, 20<strong>14</strong> ; or http://www.strategie.<br />

gouv.fr/publications/france-10-ans<br />

3. Commission nationale pour le débat public.<br />

4. written by the prefect Carrère<br />

5. known as the Barnier laws (after France’s<br />

Environment Minister)<br />

6. Except for the airport of Notre-Dame-des-<br />

Landes. In this particular case, public debate<br />

failed to prevent the deployment of strong<br />

opposition that appeared at the start of the<br />

works and that has stopped its realization.<br />

7. This paragraph has been written by Aude<br />

Teillant. See also Teillant A. (2011), Toward a<br />

responsible development of nanotechnologies,<br />

Note d’analyse, Centre d’analyse stratégique,<br />

novembre.<br />

8. For a concise presentation of the context<br />

and proceedings of the debate, see<br />

Deslandes P. (2010), Bilan du débat public<br />

sur le développement et la régulation des<br />

nanotechnologies, CNDP.<br />

9. OGM et agriculture : options pour l’action<br />

publique, septembre 2011, http://www.<br />

ladocumentationfrancaise.fr/rapportspublics/0<strong>14</strong>000692/index.shtml<br />

10. The Institute of Advanced Studies for Science<br />

and Technology organizes for professional<br />

leaders from every sector of society (research<br />

and higher education, business, media,<br />

government, elected people, associations,<br />

journalists, educators) a national training cycle<br />

where they can share their experiences of<br />

stakeholders in an international perspective.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!